These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8201590)
21. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists. Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents. Pierson ME; Comstock JM; Simmons RD; Kaiser F; Julien R; Zongrone J; Rosamond JD J Med Chem; 1997 Dec; 40(26):4302-7. PubMed ID: 9435899 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors. Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors. Horwell DC; Beeby A; Clark CR; Hughes J J Med Chem; 1987 Apr; 30(4):729-32. PubMed ID: 3560164 [TBL] [Abstract][Full Text] [Related]
25. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors. Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251 [TBL] [Abstract][Full Text] [Related]
26. Cyclic cholecystokinin analogues with high selectivity for central receptors. Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318 [TBL] [Abstract][Full Text] [Related]
27. Ac-[3- and 4-alkylthioproline31]-CCK4 analogs: synthesis and implications for the CCK-B receptor-bound conformation. Kolodziej SA; Nikiforovich GV; Skeean R; Lignon MF; Martinez J; Marshall GR J Med Chem; 1995 Jan; 38(1):137-49. PubMed ID: 7837225 [TBL] [Abstract][Full Text] [Related]
28. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands. Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691 [TBL] [Abstract][Full Text] [Related]
29. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2. Goudreau N; Weng JH; Roques BP Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585 [TBL] [Abstract][Full Text] [Related]
30. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors. Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977 [TBL] [Abstract][Full Text] [Related]
31. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists. Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region. Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230 [TBL] [Abstract][Full Text] [Related]
33. 2-Oxopiperazine-based gamma-turn conformationally constrained peptides: synthesis of CCK-4 analogues. Herrero S; García-López MT; Latorre M; Cenarruzabeitia E; Del Río J; Herranz R J Org Chem; 2002 May; 67(11):3866-73. PubMed ID: 12027705 [TBL] [Abstract][Full Text] [Related]
34. Development of CCK-B antagonists. Horwell DC Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533 [TBL] [Abstract][Full Text] [Related]
35. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors. Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338 [TBL] [Abstract][Full Text] [Related]
37. Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: relationships with affinity and selectivity for brain receptors. Roy P; Charpentier B; Durieux C; Dor A; Roques BP Biopolymers; 1989 Jan; 28(1):69-79. PubMed ID: 2720122 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity. Galas MC; Lignon MF; Rodriguez M; Mendre C; Fulcrand P; Laur J; Martinez J Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468 [TBL] [Abstract][Full Text] [Related]
39. ARL 15849: a selective CCK-A agonist with anorectic activity in the rat and dog. Simmons RD; Kaiser FC; Pierson ME; Rosamond JR Pharmacol Biochem Behav; 1998 Feb; 59(2):439-44. PubMed ID: 9476993 [TBL] [Abstract][Full Text] [Related]
40. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor. De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]